AR
Aridis Pharmaceuticals, Inc.
ARDS · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $17.8K
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
-
N/A P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
57 /100
Average ROA 209.25%
Asset turnover 0.00x
ROIC 174.87%
Debt
50 /100
Moderate Int. coverage -79.35x
Net debt/EBITDA -0.04x
Current ratio 0.32x
Stability
53 /100
Moderate EPS volatility 48.54%
Profitable years 0
Beta 0.76x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ARDS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Vu L. Truong
Employees
37
Headquarters
Los Gatos
Upcoming events
02 NOV
Earnings
Upcoming earnings report